Quality of Life of Elderly and Senile Patients with Hormone Receptor Positive Breast Cancer Using Primary Endocrine Therapy
https://doi.org/10.24884/1607-4181-2021-28-4-48-55
Abstract
Introduction. Elderly and senile patients are a special category of patients and standard methods in breast cancer treatment are not suitable due to the frequent presence of serious comorbidities and personal preferences and concerns about treatment options. Аn available treatment option for these patients with hormone-receptor positive breast cancer may be the primary endocrine therapy (PET).
The objective was to assess the quality of life of patients treated by PET or surgical treatment with adjuvant endocrine therapy (ET) and identifying the reasons of choosing a conservative treatment strategy.
Methods and materials. Our study included 65–89-year-old patients with hormone-receptor positive breast cancer with stages I–II, some of whom received only endocrine therapy (ET) (n=20), and others are prescribed adjuvant ET after surgical treatment (n=20). Quality of life was assessed by analyzing the EORTC QLQ C-30 and QLQ-BR23 questionnaires filled in by patients at different stages of treatment. An analysis of outpatient records was carried out to identify the reasons for choosing a conservative treatment strategy.
Results. The choice of conservative treatment strategy was justified by the presence of a serious concomitant pathology in 65 % of cases. Performing breast surgery was associated with a decline in the quality of life in the postoperative period.
Conclusions. PET is an alternative treatment option for some of the elderly patients with hormone-receptor positive breast cancer, since it has similar results in overall survival compared to standard complex treatment (surgery + adjuvant ET), but also does not make the quality of life worst during treatment.
About the Authors
A. G. Manikhas
St. Petersburg City Clinical Oncology Dispensary
Russian Federation
Russian Federation
Manikhas Alexey G., Dr. of Sci. (Med.), Associate Professor, Head of the Department of Surgical Methods of Treatment № 1
Saint Petersburg
D. S. Pasekova
St. Petersburg City Clinical Oncology Dispensary;
Pavlov University
Russian Federation
Russian Federation
Pasekova Daria S., Postgraduate Student of the Department of Oncology of the Faculty of Postgraduate Education, Pavlov University, Oncologist of the Department of Surgical Methods of Treatment № 1, City Clinical Oncology Center
6-8, L’va Tolstogo str., Saint Petersburg, 197022
E. E. Topuzov
St. Petersburg City Clinical Oncology Dispensary
Russian Federation
Russian Federation
Topuzov Eldar E., Dr. of Sci. (Med.), Professor, Chief Physician
Saint Petersburg
References
1. Kaprin A. D., Starinskiy V. V., Shahzadova A. O. The state of cancer care for the population of Russia in 2020. Мoscow, МNIOI of P. A. Herzen – the branch of FSBI «National Medical Research Center of Radiology» of Ministry of Health of Russia. 2021:239. (In Russ.).
2. Kiderlen M., Walsh P., Bastiaannet E., Kelly M., Audisio R., Boelens P., Brown C., Dekkers O., de Craen A., van de Velde C., Liefers G. Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland .. PLoS ONE. 2015;10(2):Е0118074. Doi: 10.1371/journal.pone.0118074.
3. Panal M., Sаnchez-Mendez J., Revello R., Abehsera D., de Santiago J., Zapardiel I. Primary Hormonal Therapy for Elderly Breast Cancer Patients: Single Institution Experience // Gynecologic and Obstetric Investigation. 2015;80(1):10–14. Doi: 10.1159/000368229.
4. Smith I., Fribbens C. Management of breast cancer in older and frail patients // Breast. 2015;(24):S159–S162. Doi: 10.1016/j.breast.2015.07.037.
5. Pepping R., Portielje J., Water W., de Glas N. Primary Endocrine Therapy in Older Women with Breast Cancer // Current Geriatric Reports. 2017;6(4):239–246. Doi: 10.1007/s13670-017-0223-z.
6. Umit Ugurlu M., Gulluoglu B. Impact of older age on local treatment decisions // Breast. 2019; 48(1):S57–S61. Doi: 10.1016/S0960-9776(19)31125-7.
7. Hilton J., Arnaout A., Clemons M. Primary endocrine therapy as an approach for patients with localized breast cancer deemed not to be surgical candidates // Current Opinion in Supportive and Palliative Care. 2014;8(1):53–58. Doi: 10.1097/SPC.0000000000000026.
8. Chan S., Chan P., Seah M., Chen J., Tan E. Limiting the use of primary endocrine therapy in elderly women with breast cancer // Annals of the Academy of Medicine of Singapore. 2014:43(9):469–472.
9. Ward S., Richards P., Morgan J., Holmes G., Broggio J., Collins K., Reed M., Wyld L. Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival // British Journal of Surgery. 2018;105(11):1454–1463. Doi: 10.1002/bjs.10885.
10. Manikhas A. G., Pasekova D. S. Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older) // Tumors of female reproductive system. 2021;17(2):32–39. (In Russ.). Doi: 10.17650/1994-4098-2021-17-2-32-38.
11. Syed B., Al-Khyatt W., Johnston S., Wong D., Winterbottm L., Kennedy H., Green A., Morgan D., Ellis I., Cheung K. Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre // British Journal of Cancer. 2011;104(9):1393–1400. Doi: 10.17650/10.1038/bjc.2011.105.
12. Morgan J., Burton M., Collins K., Lifford K., Robinson T., Cheung K., Audisio R., Reed M., Wyld L. The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer // Psycho-Oncology. 2015;24(12):1761–1766. Doi: 10.1002/pon.3853.
13. Angarita F., Elmi M., Zhang Y., Look Hong N. Patient-reported factors influencing the treatment decision making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence // Breast Cancer Research and Treatment. 2018;171(3): 545–564. Doi: 10.1007/s10549-018-4865-0.
14. Sowerbutts A., Griffiths A., Todd C., Lavelle K. Why are older women not having surgery for breast cancer? A qualitative study // Psycho-Oncology. 2015;24(9):1036–1042. Doi: 10.1002/pon.3764.
15. Takada K., Kashiwagi S., Asano Y., Goto W., Morisaki T., Takahashi K., Shibutani M., Amano R., Takashima T., Tomita S., Hirakawa K., Ohira M. Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study // Anticancer Research. 2019;39(6):2941–2950. Doi: 10.21873/anticanres.13424.
Supplementary files
Review
For citations:
Manikhas A.G., Pasekova D.S., Topuzov E.E. Quality of Life of Elderly and Senile Patients with Hormone Receptor Positive Breast Cancer Using Primary Endocrine Therapy. The Scientific Notes of the Pavlov University. 2021;28(4):48-55. (In Russ.) https://doi.org/10.24884/1607-4181-2021-28-4-48-55
Views:
505
Email this article 